Nab-paclitaxel plus gemcitabine versus FOLFIRINOX in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: A national cohort (Comunica-TTD working group). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results